$122 Million payment for a drug that is helpful on
Post# of 72440
(Total Views: 143)
Posted On: 11/09/2017 11:04:30 AM
$122 Million payment for a drug that is helpful only for a small number of people (relatively speaking) -- a drug that reduces rate of cytomegalovirus infection in bone marrow transplant patients from about 60% to about 37%. That isn't exactly a stellar result (though great for those who avoid infection because of the drug). Cost, about $200/day wholesale price, $270/day retail.
So what kind of payment do you think would be triggered for an oral rinse that prevents oral mucositis in a much larger patient population? The number of head and neck cancer patients who would use Brilacidin-OM is far larger, and if the use is widened to all chemo and radiation patients who are at risk for OM, it will be even larger.
https://endpts.com/merck-wins-fda-ok-for-new-...%20AiCuris
So what kind of payment do you think would be triggered for an oral rinse that prevents oral mucositis in a much larger patient population? The number of head and neck cancer patients who would use Brilacidin-OM is far larger, and if the use is widened to all chemo and radiation patients who are at risk for OM, it will be even larger.
https://endpts.com/merck-wins-fda-ok-for-new-...%20AiCuris
(2)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼